C4ORF36 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.003200E-01
Normal-vs-Stage2
4.273400E-01
Normal-vs-Stage3
9.920400E-01
Normal-vs-Stage4
4.605000E-01
Stage1-vs-Stage2
8.049000E-04
Stage1-vs-Stage3
7.792600E-01
Stage1-vs-Stage4
3.647400E-01
Stage2-vs-Stage3
3.520800E-01
Stage2-vs-Stage4
6.006600E-01
Stage3-vs-Stage4
4.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.521400E-01
Normal-vs-AfricanAmerican
3.853800E-01
Normal-vs-Asian
7.377800E-01
Caucasian-vs-AfricanAmerican
8.651200E-01
Caucasian-vs-Asian
5.057600E-01
AfricanAmerican-vs-Asian
4.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.485800E-01
Normal-vs-Female
5.712400E-01
Male-vs-Female
3.163000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.183200E-01
Normal-vs-Age(41-60Yrs)
4.467800E-01
Normal-vs-Age(61-80Yrs)
5.989000E-01
Normal-vs-Age(81-100Yrs)
5.018000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.766400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.778800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.399600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.464400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.928200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.230800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.844000E-01
Normal-vs-Daily Drinker
7.574800E-01
Normal-vs-Weekly Drinker
6.415000E-01
Normal-vs-Occasional Drinker
2.872600E-01
Normal-vs-Social Drinker
5.103400E-01
Non Drinker-vs-Daily Drinker
3.055000E-01
Non Drinker-vs-Weekly Drinker
7.006200E-01
Non Drinker-vs-Occasional Drinker
3.530400E-01
Non Drinker-vs-Social Drinker
3.045200E-01
Daily Drinker-vs-Weekly Drinker
6.393600E-01
Daily Drinker-vs-Occasional Drinker
6.657800E-02
Daily Drinker-vs-Social Drinker
1.967360E-01
Weekly Drinker-vs-Occasional Drinker
2.717800E-01
Weekly Drinker-vs-Social Drinker
2.579800E-01
Occasional Drinker-vs-Social Drinker
4.682800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.261800E-01
Normal-vs-Grade 2
9.785500E-02
Normal-vs-Grade 3
1.016840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.952400E-01
Grade 1-vs-Grade 3
3.352000E-01
Grade 1-vs-Grade 4
6.261800E-01
Grade 2-vs-Grade 3
2.920400E-02
Grade 2-vs-Grade 4
9.785500E-02
Grade 3-vs-Grade 4
1.016840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.108000E-01
Normal-vs-NonDiabetic
5.656000E-01
Diabetic-vs-NonDiabetic
3.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.452200E-01
Normal-vs-NoPancreatitis
5.754200E-01
Pancreatitis-vs-NoPancreatitis
5.981400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.511400E-01
Normal-vs-N1
4.078200E-01
N0-vs-N1
7.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.512400E-01
Normal-vs-TP53-NonMutant
6.647400E-01
TP53-Mutant-vs-TP53-NonMutant
4.278200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
